All
FDA Approves Lynparza as First-Line Maintenance Treatment for Metastatic Pancreatic Cancer
December 30th 2019The Food and Drug Administration approved the first PARP inhibitor for the maintenance treatment of adult patients with deleterious or suspected deleterious germline BRCA-mutated metastatic pancreatic adenocarcinoma.
Stepping Out from Under the Umbrella of Fear
December 25th 2019A diagnosis of breast cancer can cause a person to become very fearful especially when the future holds so many unknowns, but it’s not healthy to live under an umbrella of fear. In this article, survivor, Bonnie Annis, shares her experience.
Winter Is Coming: How People with Cancer Can Prevent Slips and Falls
December 23rd 2019Falls are a risk for everyone during slushy winter months, but the risk is especially high for people with cancer. Memorial Sloan Kettering physical therapist Jillian Hobson walks readers through what they can do to minimize the chance of falling.
In Early Recurrent Liver Cancer, Surgery and Radiofrequency Ablation Spark Similar Survival Benefits
December 19th 2019Radiofrequency ablation was statistically on par with surgery when it came to survival after an early recurrence of liver cancer, but surgery provided more benefit if the disease was a bit more advanced.